Science News

Stay updated with the latest scientific news and research. Read press releases covering groundbreaking discoveries, innovations, and developments across various scientific fields. Keep up with the advancements and insights shaping the future of science.

Jan 16, 2026 at 4:01 PM

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on January 15, 2026, it granted stock options to purchase an aggregate of 74,020 shares of common stock to nine...
Jan 16, 2026 at 2:48 PM

Emmecell Appoints Ramin Valian as Chief Executive Officer to Advance Magnetic Cell Delivery Platform

MENLO PARK, Calif.--(BUSINESS WIRE)--Emmecell announces the appointment of ophthalmology leader Ramin Valian as CEO....
Jan 16, 2026 at 12:15 PM

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...
Jan 16, 2026 at 11:22 AM

Rompower’s “Ideal Flyback” in 800V Bus Applications

TUCSON, Ariz.--(BUSINESS WIRE)--Rompower’s Ideal Flyback topology overcomes the fundamental limitations of conventional flyback converters while preserving the simplicity and cost advantages of a single-switch architecture. By harvesting a portion of the transformer’s leakage-inductance energy, without the use of additional switch, and repurposing it to achieve true zero-voltage switching (ZVS) in all the operating conditions, the Ideal Flyback delivers a step change in switching performance an...
Jan 16, 2026 at 9:00 AM

Alexander Group Survey: 78% of Executives Cite AI Adoption as Leading Driver of Growth and Efficiency

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Alexander Group, the premier go-to-market consultancy serving clients around the globe, announced the results of its 2026 Innovating Customer Engagement with AI research, which polled commercial executives on their organizations’ AI adoption. More than three-quarters (78%) of respondents said that AI was driving revenue growth; by contrast, 61% said that inflation and interest rates were driving revenue decline, and 45% described industry competition as such....
Jan 16, 2026 at 8:30 AM

People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®

BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation of Tiffany Howard, recently featured in People magazine. Tiffany’s journey highlights how OPTAVIA’s comprehensive program, which combines science-backed nutrition, personalized coaching and sustainable habit-building, reversed her metabolic dysfunction1. For Tiffany, this meant several meaningful he...
Jan 16, 2026 at 8:00 AM

Autobahn Therapeutics Presents New Preclinical Data at ACNP Annual Meeting Supporting Novel Restorative Neuroplasticity Mechanism of Elunetirom

SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the presentation of new preclinical data for elunetirom, the company’s lead asset currently in Phase 2 clinical development for adjunctive major depressive disorder (MDD) and bipolar depression, at the 64th Annual American College of Neuropsychopharmacology (ACNP) Annual Meeting taking place in Nassau...
Jan 15, 2026 at 2:00 PM

Portal Atlanta at Science Square Grows to Over 30 Member Companies, Marking Major Milestone 15 Months After Launch

ATLANTA--(BUSINESS WIRE)--Portal Innovations announced continued growth at Portal Atlanta at Science Square, with the addition of seven new member companies, bringing the total ecosystem to 32 biotech, medtech, digital health, and cleantech, organizations served, just 15 months after launch. The milestone – which includes 7 new members in just the month of January 2026 alone – highlights the rapid momentum building around Science Square and Atlanta’s expanding life sciences and medtech communit...
Jan 15, 2026 at 1:18 PM

Viz.ai and Salesforce Collaborate to Transform Pharma Engagement With Real-Time Clinical Intelligence for Agentforce

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new real-time clinical intelligence service for Salesforce’s Agentforce Life Sciences. These services will power new and existing agentic solutions for life sciences customers, including a data integration that will bring Viz.ai’s real-time data, triggers, and clinical intelligence layer from across a network of nearly 2,000 hospitals covering 230...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up